University Hospitals Birmingham NHS Foundation Trust

Status Drug name NICE TAs Comments Subchapter
Status: Red Andexanet alfa (Ondexxya®) 18.2
Status: Red Ankynzeo® (Netupitant and Palonosetron) capsules

For use with chemotherapy only - replace aprepitant capsules

4.6
Status: Green Anoro® Ellipta® 55/22mcg (multi dose dry powder inhaler device)

To be used in line with COPD guidance

3.1
Status: Red Antacid and oxetacaine suspension 150ml

Suspension - specialist use only

1.1
Status: Green Anthelios XL® 13.8
Status: Red Anti-D (Rh0) immunoglobulin 14.5
Status: Red Anti-thymocyte globulin (equine) injection 8.2
Status: Red Anti-thymocyte globulin (rabbit) injection 8.2
Status: Green Anusol cream 1.7
Status: Green Anusol HC ointment 1.7

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top